Journal of Cancer Treatment and Research

Volume 8, Issue 2, June 2020

  • Selected Personal Factors as Predictors of Quality of Life of Cancer Patients in Southwestern Nigeria

    Alice Obianiberi Ntekim, Chioma Christiana Asuzu, Jonathan Ohiorenuan Osiki, Atara Isaiah Ntekim

    Issue: Volume 8, Issue 2, June 2020
    Pages: 29-33
    Received: 29 February 2020
    Accepted: 13 March 2020
    Published: 31 March 2020
    Downloads:
    Views:
    Abstract: The incidence of cancer across the globe has shown that the disease is a leading cause of death worldwide; and it accounted for 7.6 million deaths, which is about 13% of all deaths in 2018. Also, deaths from cancer worldwide are projected to be rising, with an estimated 12 million deaths in 2030. In spite of the efforts of stakeholders to control t... Show More
  • An Exploration of the Active Ingredients of Salvia miltiorrhiza in the Treatment of Gastric Cancer and Its Mechanism Based on Network Pharmacology

    Xiongdong Zhong

    Issue: Volume 8, Issue 2, June 2020
    Pages: 34-44
    Received: 10 April 2020
    Accepted: 6 May 2020
    Published: 19 May 2020
    Downloads:
    Views:
    Abstract: BACKGROUND: Danshen, also known as Salvia miltiorrhiza or radix salvia in Latin, is an important drug whose main pharmacological effects are vasodilation, promotion of blood circulation, and elimination of stasis. In recent years, it has been reported that danshen also has anti-tumor activity. OBJECTIVE: The aim of this study was to explore the fea... Show More
  • Immunotherapy Related Adverse Events Predict Treatment Response

    Diana Maslov, Katharine Thomas, Victoria Simenson, Caitlin Sullivan, Alaa Mohammed, Jessica Boyce, Marc Matrana

    Issue: Volume 8, Issue 2, June 2020
    Pages: 45-50
    Received: 17 May 2020
    Accepted: 28 May 2020
    Published: 9 June 2020
    Downloads:
    Views:
    Abstract: Immunotherapy blocks immunoinhibitory pathways and allows for reversal of immunosuppression caused by malignant tumors. Immunotherapy can cause immune-related adverse events (IrAE) including rash, pneumonitis, colitis endocrinopathy, nephritis, adrenal insufficiency, hepatitis, and uveitis. Limited data exist to predict which patients will have the... Show More